Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Finance / Czech Republic

Turkish Acquisition Drives Sales For Zentiva

March 2008 | Company Finance Alert

In 2007, Czech drugmaker Zentiva's sales grew by 19% to CZK16.7bn (US$1.03bn), due mainly to the acquisition of Turkish drug firm Eczacibaşi in March 2007 for EUR460mn

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
7% P&R Reductions Scheduled For January 2010

Industry / Czech Republic Prospects for growth in the Czech Republic's US$4.2bn pharmaceutical market appear ominous for 2010, pending the resolution of challenges to pricing legislation proposed in late 2009. In an effort to...
December 2009
SÚKL Registry Raises Data Protection Questions

Industry / Czech Republic The role of the Czech Republic's State Institute for Drug Control (SÚKL) in collecting information about the prescribing and dispending of medicine has come under scrutiny, following investigations...
August 2009
Schlecker Targets Czech Republic

Industry / Czech Republic German drug store chain
October 2007
Internet Pharmacies Blossoming After De-regulation

Industry / Czech Republic The number of online pharmacies in the Czech Republic has grown rapidly after the government repealed laws prohibiting the sale of drugs over the internet. There are currently 74 e-pharmacies with many...
October 2007
Zentiva Expands Eastwards

Industry / Czech Republic Czech drugmaker Zentiva recorded a disappointing performance on its home market in H107 with sales receding 5.6% to CZK2,226mn (US$115.08mn). Chief Financial Officer Petr Sulc blames recent drug market...
October 2007
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS